Bessard M, Moser A, Waeckel-Enee E, Lindo V, Gdoura A, You S
Front Immunol. 2024; 15:1474453.
PMID: 39600694
PMC: 11588737.
DOI: 10.3389/fimmu.2024.1474453.
Park C, Shin S, Han S
Nutrients. 2024; 16(18).
PMID: 39339785
PMC: 11435169.
DOI: 10.3390/nu16183185.
Dwyer A, Shaheen Z, Fife B
Front Immunol. 2024; 15:1440045.
PMID: 39211046
PMC: 11358097.
DOI: 10.3389/fimmu.2024.1440045.
Selck C, Jhala G, De George D, Kwong C, Christensen M, Pappas E
Proc Natl Acad Sci U S A. 2024; 121(6):e2315419121.
PMID: 38285952
PMC: 10861925.
DOI: 10.1073/pnas.2315419121.
James E, Joglekar A, Linnemann A, Russ H, Kent S
Mol Metab. 2023; 78:101809.
PMID: 37734713
PMC: 10622886.
DOI: 10.1016/j.molmet.2023.101809.
Monitoring immunomodulation strategies in type 1 diabetes.
Krishnamurthy B, Lacorcia M, Kay T, Thomas H, Mannering S
Front Immunol. 2023; 14:1206874.
PMID: 37346035
PMC: 10279879.
DOI: 10.3389/fimmu.2023.1206874.
Vitamin D in Diabetes: Uncovering the Sunshine Hormone's Role in Glucose Metabolism and Beyond.
Wu J, Atkins A, Downes M, Wei Z
Nutrients. 2023; 15(8).
PMID: 37111216
PMC: 10142687.
DOI: 10.3390/nu15081997.
Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes?.
Eizirik D, Szymczak F, Mallone R
Nat Rev Endocrinol. 2023; 19(7):425-434.
PMID: 37072614
DOI: 10.1038/s41574-023-00826-3.
I-A β56/57 polymorphisms regulate non-cognate negative selection to CD4 T cell orchestrators of type 1 diabetes.
Stadinski B, Cleveland S, Brehm M, Greiner D, Huseby P, Huseby E
Nat Immunol. 2023; 24(4):652-663.
PMID: 36807641
PMC: 10623581.
DOI: 10.1038/s41590-023-01441-0.
Islet-specific CD8 T cells gain effector function in the gut lymphoid tissues via bystander activation not molecular mimicry.
Okada M, Zhang V, Loaiza Naranjo J, Tillett B, Wong F, Steptoe R
Immunol Cell Biol. 2022; 101(1):36-48.
PMID: 36214093
PMC: 10092732.
DOI: 10.1111/imcb.12593.
Autoreactive CD8 T cells are restrained by an exhaustion-like program that is maintained by LAG3.
Grebinoski S, Zhang Q, Cillo A, Manne S, Xiao H, Brunazzi E
Nat Immunol. 2022; 23(6):868-877.
PMID: 35618829
PMC: 9179227.
DOI: 10.1038/s41590-022-01210-5.
Oral Fc-Coupled Preproinsulin Achieves Systemic and Thymic Delivery Through the Neonatal Fc Receptor and Partially Delays Autoimmune Diabetes.
Corcos N, Culina S, Deligne C, Lavaud C, You S, Mallone R
Front Immunol. 2021; 12:616215.
PMID: 34447366
PMC: 8382691.
DOI: 10.3389/fimmu.2021.616215.
The dark side of insulin: A primary autoantigen and instrument of self-destruction in type 1 diabetes.
Harrison L
Mol Metab. 2021; 52:101288.
PMID: 34242821
PMC: 8513143.
DOI: 10.1016/j.molmet.2021.101288.
Tolerance to Proinsulin-1 Reduces Autoimmune Diabetes in NOD Mice.
Jhala G, Selck C, Chee J, Kwong C, Pappas E, Thomas H
Front Immunol. 2021; 12:645817.
PMID: 33841427
PMC: 8027244.
DOI: 10.3389/fimmu.2021.645817.
Optimization of a Method to Detect Autoantigen-Specific T-Cell Responses in Type 1 Diabetes.
Musthaffa Y, Nel H, Ramnoruth N, Patel S, Hamilton-Williams E, Harris M
Front Immunol. 2021; 11:587469.
PMID: 33424839
PMC: 7793893.
DOI: 10.3389/fimmu.2020.587469.
B Quiet: Autoantigen-Specific Strategies to Silence Raucous B Lymphocytes and Halt Cross-Talk with T Cells in Type 1 Diabetes.
Felton J, Conway H, Bonami R
Biomedicines. 2021; 9(1).
PMID: 33418839
PMC: 7824835.
DOI: 10.3390/biomedicines9010042.
Advances and complications of regenerative medicine in diabetes therapy.
Brovkina O, Dashinimaev E
PeerJ. 2020; 8:e9746.
PMID: 33194345
PMC: 7485501.
DOI: 10.7717/peerj.9746.
CD226 Deletion Reduces Type 1 Diabetes in the NOD Mouse by Impairing Thymocyte Development and Peripheral T Cell Activation.
Shapiro M, Yeh W, Longfield J, Gallagher J, Infante C, Wellford S
Front Immunol. 2020; 11:2180.
PMID: 33013915
PMC: 7500101.
DOI: 10.3389/fimmu.2020.02180.
Characterization of Proinsulin T Cell Epitopes Restricted by Type 1 Diabetes-Associated HLA Class II Molecules.
Ihantola E, Ilmonen H, Kailaanmaki A, Rytkonen-Nissinen M, Azam A, Maillere B
J Immunol. 2020; 204(9):2349-2359.
PMID: 32229538
PMC: 9022012.
DOI: 10.4049/jimmunol.1901079.
A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H, Fukuda-Kawaguchi E, Duramad O, Ishii Y, Tanabe K
J Diabetes Res. 2019; 2019:9430473.
PMID: 31781669
PMC: 6855036.
DOI: 10.1155/2019/9430473.